Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models.

Imaging PEG-like nanoprobes in tumor, transient ischemia, and inflammatory disease models.
复制标题

肿瘤、短暂性缺血和炎症疾病模型中的类 PEG 纳米探针成像。

DOI:
10.1021/acs.bioconjchem.5b00213
复制
发表时间:
2015
影响因子:
4.7
通讯作者:
Josephson,Lee
Josephson,Lee
中科院分区:
化学2区
文献类型:
--
作者:
Wilks,MosesQ;Normandin,MarcD;Yuan,Hushan;Cho,Hoonsung;Guo,Yanyan;Herisson,Fanny;Ayata,Cenk;Wooten,DustinW;ElFakhri,Georges;Josephson,Lee

文献摘要

参考文献

被引文献

相似文献

铁螯合剂去铁胺(DFO),批准用于治疗铁过载,已被检查作为一种治疗在各种条件下,铁可能加剧。为了评估携带DFO的PEG样纳米探针(DFO-PN)作为治疗剂的潜力,我们确定了它们在正常小鼠中的药代动力学(PK),并对它们在肿瘤模型和短暂脑缺血和炎症模型中的积累进行了成像。DFO-PN由连接至Lys-Cys支架的DFO、Cy5.5和PEG(5 kDa或30 kDa)组成。通过PET、表面荧光和荧光显微镜对[89 Zr]:DFO-PN(10)(30 kDa PEG,直径10 nm)的肿瘤摄取进行成像。DFO-PN(10)被肿瘤细胞(荧光显微镜)和培养细胞(通过FACS)内化。[89 Zr]:DFO-PN(4.3)(5 kDa PEG,直径4.3 nm)浓缩在切口处产生炎症,但在短暂脑缺血部位不产生炎症。DFO-PN是DFO的荧光、PK可调形式,可作为抗肿瘤或抗炎剂进行研究。
The iron chelator deferoxamine (DFO), approved for the treatment of iron overload, has been examined as a therapeutic in a variety of conditions which iron may exacerbate. To evaluate the potential of DFO-bearing PEG-like nanoprobes (DFO-PNs) as therapeutics, we determined their pharmacokinetics (PK) in normal mice, and imaged their accumulation in a tumor model and in models of transient brain ischemia and inflammation. DFO-PNs consist of a DFO, a Cy5.5, and PEG (5 kDa or 30 kDa) attached to Lys-Cys scaffold. Tumor uptake of a [89Zr]:DFO-PN(10) (30 kDa PEG, diameter 10 nm) was imaged by PET, surface fluorescence, and fluorescence microscopy. DFO-PN(10) was internalized by tumor cells (fluorescence microscopy) and by cultured cells (by FACS). [89Zr]:DFO-PN(4.3) (5 kDa PEG, diameter 4.3 nm) concentrated at incision generated inflammations but not at sites of transient brain ischemia. DFO-PNs are fluorescent, PK tunable forms of DFO that might be investigated as antitumor or anti-inflammatory agents.
DOI: 10.1021/bc4000349
发表时间: 2013-07-01
影响因子: 4.7
作者:
Pauli, Jutta;Licha, Kai;Resch-Genger, Ute
通讯作者: Resch-Genger, Ute
DOI: 10.1021/ja309085b
发表时间: 2012-11-28
影响因子: 15
作者:
Guo, Yanyan;Yuan, Hushan;Rice, William L.;Kumar, Anand T. N.;Goergen, Craig J.;Jokivarsi, Kimmo;Josephson, Lee
通讯作者: Josephson, Lee
去铁胺治疗对类风湿性关节炎相关慢性贫血的影响
DOI: 10.1007/bf01816434
发表时间: 2005
影响因子: 4
作者:
C. Salvarani;R. Baricchi;D. Lasagni;L. Boiardi;R. Piccinini;C. Brunati;P. Macchioni;I. Portioli
通讯作者: I. Portioli
羟乙基淀粉结合的去铁胺对慢性神经受压缺血/再灌注损伤的影响
DOI: 10.1055/s-2007-1000211
发表时间: 1998
影响因子: 2.1
作者:
P. Marin;M. Im;J. Girotto;G. Borschel;Kyle Bickel
通讯作者: Kyle Bickel
铁(III)螯合剂去铁胺对人恶性黑色素瘤细胞吸收铁和转铁蛋白的影响。
DOI: --
发表时间: 1994
期刊: Cancer Research
影响因子: 11.2
作者:
D. Richardson;P. Ponka;E. Baker
通讯作者: E. Baker